Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Use of Aspirin as Primary Prevention in Patients with Diabetes
2014-003064-21Phase 4Active
- Sponsor
- Hospital Universitari de Girona Dr. Josep Trueta
- Start
- Sep 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of aspirin in diabetes mellitus type 1 (T1D), type 2 diabetes mellitus (T2DM), diabetes mellitus (DM) and 1 more (3 arms), sponsored by Hospital Universitari de Girona Dr. Josep Trueta. Primary endpoints: Degree of antiplatelet therapy and Phenotypic characterization by platelet reactivity. Started Sep 2014; status: active.
02
Drugs
aspirin
03
Conditions
diabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)diabetes mellitus (DM)cardiac morbidity
Beyond the preview
Go deeper on 2014-003064-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003064-21.